Panacea Biotec (BOM:531349) 3-Year Revenue Growth Rate : -5.30% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Panacea Biotec 3-Year Revenue Growth Rate?

Panacea Biotec's Revenue per Share for the three months ended in Dec. 2023 was ₹25.31.

During the past 12 months, Panacea Biotec's average Revenue per Share Growth Rate was 18.70% per year. During the past 3 years, the average Revenue per Share Growth Rate was -5.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was 0.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was -1.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Panacea Biotec was 27.50% per year. The lowest was -23.30% per year. And the median was 0.85% per year.

Competitive Comparison of Panacea Biotec's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, Panacea Biotec's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Panacea Biotec's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Panacea Biotec's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Panacea Biotec's 3-Year Revenue Growth Rate falls into.

Panacea Biotec 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Panacea Biotec (BOM:531349) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Panacea Biotec 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Panacea Biotec's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Panacea Biotec (BOM:531349) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacea Biotec Ltd (BOM:531349) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

PANACEABIO:India

Address

Mathura Road, B-1 Extn./G-3, Mohan Co-operative Industrial Estate, New Delhi, IND, 110 044

Website

https://www.panaceabiotec.com

Panacea Biotec Ltd is a Biotechnology company. It is engaged in the business of research, development, manufacturing, and marketing of branded pharmaceutical formulations, vaccines, and biopharmaceuticals. The company's operating segments include Vaccines, and Formulations. It generates maximum revenue from the Vaccines segment. The company product portfolio includes prescription products in niche therapeutic areas such as diabetes and cardiovascular management, oncology, nephrology and transplant management, osteoporosis management, gastro-intestinal care, pain management products, and pediatric immunization. The group has a business presence in India and Outside India.

Panacea Biotec (BOM:531349) Headlines

No Headlines